Wechselwirkungen · Ilaris
Ilaris 150 mg/ml solution for injection Ilaris 150 mg solution for injection in pre-filled pen · Abschnitt 4.5 · PDF-Seite 9
HOS-122015 · Präparat HOS-095465
No data are available on either the effects of live vaccination or the secondary transmission of infection by live vaccines in patients receiving canakinumab. Therefore, live vaccines must not be given concurrently with canakinumab unless the benefits clearly outweigh the risks. In case vaccination with live vaccines is indicated after initiation of canakinumab treatment, the recommendation is to wait for at least 3 months after the last canakinumab injection and before the next one (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-05T15:45:00Z · SHA-256 dab74bfeca2bcb286b07151a7bc327aaa62f3eb7f0ded500ec062f70f9bdfb5a · Passage e41e3ddb5e922313bf189d63ff509c14d6db14a6dfff4d9700c4a79cb0219183 · Zeichen 1043–1549 im Abschnitt